Medical devices

Draft Commission Implementing Decision on the group of products whose principal intended action, depending on proanthocyanidins (PAC) present in cranberry (Vaccinium Macrocarpon), is to prevent or treat cystitis (3 pages, in English)

This draft Commission Decision aims at qualifying the group of products whose principal intended action, depending on proanthocyanidins (PAC) present in cranberry (Vaccinium Macrocarpon), is to prevent or treat cystitis as not medical devices.